11 December 2019 - - US-based digital genome engineering specialist Inscripta, Inc has raised USD 125m in a Series D financing with support from the company's existing investors and new investors JS Capital Management LLC and Oak HC/FT. Paladin Capital Group led the round, bringing the total amount raised by the company to USD 259.5m, the company said.

The new funds will be used to accelerate applications expansion and commercialisation of the company's revolutionary Onyx Digital Genome Engineering platform.

The Onyx platform is the world's first fully automated benchtop instrument for genome-scale engineering.

Consisting of an instrument, consumables, software, and assays, it enables scientists to create libraries of millions of precisely engineered single cells in one experiment through a fully automated workflow.

The new platform offers immediate and significant benefits that will give scientists in genome discovery, healthcare, bio-industrial materials development and manufacturing, and sustainability the power to design, engineer, evaluate, and track results of genome engineering experiments in their own labs.

Inscripta is developing the world's first benchtop platform for scalable digital genome engineering.

The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale.

Inscripta's goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7 CRISPR nuclease free for research and development purposes, the company enables scientists to realize a new era of biological discovery.

Headquartered in Boulder, Colo., with offices in Pleasanton, Calif., and San Diego, Inscripta is backed by leading investors including Venrock, Foresite, Paladin Capital Group, Mérieux Développement, NanoDimension, MLS Capital, JS Capital Management LLC, and Oak HC/FT.